Murine viral hepatitis involves NK cell depletion associated with virus-induced apoptosis

Clinical and Experimental Immunology

Volumn 137, Issue 1, 2004, Pages 41-51

  Lehoux, M ^a   Jacques, A ^a   Lusignan, S ^a   Lamontagne, L ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Apoptosis; IL 15; Mouse hepatitis virus; Natural immunity; NK cells

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 5; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL ACTIVITY; CELL POPULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; IMMUNITY; IMMUNOPATHOLOGY; IN VIVO STUDY; LIVER; LYMPHOCYTE DEPLETION; LYMPHOID CELL; MOUSE; MURINE HEPATITIS CORONAVIRUS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL; VIRUS HEPATITIS;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; BONE MARROW CELLS; CELL LINE; CORONAVIRUS INFECTIONS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HEPATITIS, VIRAL, ANIMAL; IMMUNITY, NATURAL; INTERLEUKIN-15; KILLER CELLS, NATURAL; LIVER; MICE; MICE, INBRED C57BL; MURINE HEPATITIS VIRUS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPLEEN; VIRUS REPLICATION;

EID: 3042785085     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02501.x     Document Type: Article

References (39)

1. Brinton MA, Nathanson N. Genetic determinants of virus susceptibility: epidemiologic implication of murine models. Epidemiol Rev 1981; 3:115-39.
2. Byrne JA, Oldstone MBA. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J Virol 1985; 51:682-6.
3. Sissons JPG, Borysiewicz LK. Viral immunopathology. Br Med Bull 1985; 41:34-40.
4. + cells and other natural effector cells. New York: Academic Press, 1982.
5. Gosselin J, Tomoiu A, Gallo RC, Flamand L. Interleukin-15 as an activator of natural killer cell-mediated antiviral response. Blood 1999; 94:4210-19.
6. Crotta S, Stilla A, Wack A et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 2002; 195:35-41.
7. Tseng CTK, Klimpel GR. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell function. J Exp Med 2002; 195:43-9.
8. + T cells are present within a population of intermediate TCR cells. J Immunol 1995; 155:2972-83.
9. Tsukahara A, Seki S, Iai T et al. Mouse liver T cells: their change with aging and in comparison with peripheral T cells. Hepatology 1997; 26:301-9.
10. Moore TA, Bennett M, Kumar V. Murine natural killer cell differentiation: past, present and future. Immunol Res 1996; 15:151-62.
11. + cells and the bone marrow microenvironment: where does IL-15 fit in? Res Immunol 1997; 148:195-201.
12. Le Prevost C, Levy-Leblond E, Virelizier JL, Dupuy JM. Immunopathology of mouse hepatitis virus type 3 infection. I. Role of humoral and cell-mediated immunity in resistance mechanism. J Immunol 1975; 114:221-5.
13. Levy-Leblond E, Oth O, Dupuy JM. Genetic study of mouse sensivity to MHV3 infection: influence of the H-2 complex. J Immunol 1979; 112:1359-62.
14. Dupuy JM, Levy-Leblond E, Le Prevost C. Immunopathology of mouse hepatitis virus type 3 infection. II. Effect of immunosuppression in resistant mice. J Immunol 1975; 114:221-5.
15. + B lymphocytes subpopulations. J Immunol 1989; 143:3722-30.
16. Lamontagne L, Descoteaux JP, Jolicoeur P. Mouse hepatitis virus 3 replication in T and B lymphocytes correlate with viral pathogenicity. J Immunol 1989; 142:4458-65.
17. Lamontagne L, Dupuy JM. Persistent infection with mouse hepatitis virus 3 in mouse lymphoid cell lines. Infect Immun 1984; 44:716-23.
18. Lamontagne L, Jolicoeur P. Mouse hepatitis virus 3 thymic cell interactions correlating with viral pathogenicity. J Immunol 1991; 146:3152-9.
19. high T-cell population. Immunology 1997; 160:376-84.
20. inter or NK-T cells. Clin Immunol 2001; 101:345-56.
21. Schindler L, Engler H, Kirchner H. Activation of natural killer cells and induction of interferon after injection of mouse hepatitis virus type 3 in mice. Infect Immun 1982; 35:869-73.
22. Stohlman SA, Brayton PR, Harmon RC, Stevenson D, Ganges RG, Matsushima GK. Natural killer cell activity during mouse hepatitis virus infection, response in the absence of interferon. Int J Cancer 1983; 31:309-14.
23. Mello IG, Vassao RC, Pereira CA. Virus specificity of the antiviral state induced by IFN gamma correlates with the resistance to MHV3 infection. Arch Virol 1993; 132:281-9.
24. + cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol 1983; 131:1531-8.
25. Tardieu M, Hery C, Dupuy JM. Neonatal susceptibility to MHV3 infection in mice. II. Role of natural effector marrow cells in transfer of resistance. J Immunol 1980; 124:418-23.
26. Dupuy JM, Rodrigue D. Heterogeneity in evolutive patterns of inbred mice infected with a cloned substrain of mouse hepatitis virus type 3. Intervirology 1981; 16:114-17.
27. Natuk RJ, Welsh RM. Accumulation and chemostaxis of natural killer/ large granular lymphocytes at sites of virus replication. J Immunol 1987; 138:877-83.
28. McIntyre KW, Welsh RM. Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection. J Exp Med 1986; 164:1667-81.
29. - cells from multipotential murine bone marrow progenitor in a stroma free culture: definition of cytokine requirements and developmental intermediates. J Exp Med 1997; 186:1609-14.
30. + cells from hemopoietic progenitors induced by interleukin-15. J Leuk Biol 1999; 66:659-66.
31. Tan K, Zelus BD, Meijers R et al. Crystal structure of murine sCEACAM1a[1,4]: a coronavirus receptor in the CEA family. EMBO J 2002; 21:2076-86.
32. Godfraind C, Kilgreth SG, Cardellichio CB et al. Tissue and cellular distribution of an adhesion molecule in the carcinoembryonic antigen family that serves as receptor for mouse hepatitis virus. Lab Invest 1995; 73:615-27.
33. Godfraind C, Coutelier JP. Morphological analysis of mouse hepatitis virus A59-induced pathology with regard to viral receptor expression. Histol Histopathol 1998; 13:181-99.
34. Moller MJ, Kammerer R, Grunert F, von Kleist S. Biliary glycoprotein (BGP) expression on T cells and on a natural-killler-cell subpopulation. Int J Cancer 1996; 65:740-5.
35. Lamontagne L, Décarie D, Dupuy JM. Host cell resistance to mouse hepatitis virus type 3 is expressed in vitro in macrophages and lymphocytes. Viral Immunol 1989; 2:37-45.
36. Belyavsky M, Belyavskaya E, Levy GA, Leibowitz JL. Coronavirus MHV3-induced apoptsis in macrophages. Virology 1998; 250:41-9.
37. Belyavsky M, Levy GA, Leibowitz JL. The pattern of induction of apoptosis during infection with MHV3 correlates with strain variation in resistance and susceptibility to lethal hepatitis. Adv Exp Med Biol 1998; 440:619-25.
38. An S, Chen C, Yu X, Leibowitz JL, Makino S. Induction of apoptosis in murine coronavirus-infected cultured cells and demonstration of E protein as an apoptosis inducer. J Virol 1999; 73:7853-9.
39. Jolicoeur P, Lamontagne L. Impaired T and B cells subpopulations involved in a chronic disease induced by mouse hepatitis virus type 3. J Immunol 1994; 153:1318-27.